BILL ANALYSIS                                                                                                                                                                                                    



                                                                  AB 1916
                                                                  Page  1

          Date of Hearing:   April 20, 2010

              ASSEMBLY COMMITTEE ON BUSINESS, PROFESSIONS AND CONSUMER  
                                     PROTECTION
                                 Mary Hayashi, Chair
                     AB 1916 (Davis) - As Amended:  April 8, 2010
           
          SUBJECT  :   Pharmacies: prescriptions: reports.

           SUMMARY  :   Requires a pharmacy to report to the Board of  
          Pharmacy (Board) any known occurrence of a prescription being  
          furnished to a person other than the patient named on the  
          prescription or that patient's representative.  Requires the  
          report to include any adverse reaction that may have occurred as  
          a result of the person to whom the prescription was furnished  
          using the prescribed drug.

           EXISTING LAW  

          1)Provides for the licensure and regulation of pharmacies by the  
            Board.

          2)Authorizes a pharmacy to furnish dangerous drugs only to,  
            among others, a patient or another pharmacy pursuant to a  
            prescription or as otherwise authorized by law. 

          3)Requires every pharmacy to establish a quality assurance  
            program to assess errors in dispensing or furnishing  
            prescription drugs.  A knowing violation of the Pharmacy Law  
            is a crime unless otherwise specified.

           FISCAL EFFECT  :   Unknown

           COMMENTS  :   

           Purpose of this bill .  According to the author's office,  
          "Pharmacists aren't required to notify the state when an error  
          occurs.  The responsibility currently falls on the patient.  It  
          is the author's belief that this burden to report when a  
          pharmacy has made a medical error should not be placed on the  
          patient.  The burden to report pharmacy medical errors should be  
          on the pharmacy which made the error."

           Background  .  The Board's mission is to protect the health,  
          safety, and welfare of Californians by reviewing, evaluating,  








                                                                  AB 1916
                                                                  Page  2

          and resolving consumer complaints regarding pharmacists.  The  
          Board states that suspected pharmacist misconduct or a  
          prescription filling error may be violations of the law that  
          should be reported, whether or not the patient was harmed.  The  
          Board considers prescription errors to be incorrect information  
          entered on the prescription label, or a prescription that is  
          dispensed with the wrong drug or dosage, among others.  

          According to a 2006 report by the Institute of Medicine of the  
          National Academies, medication errors (preventable adverse drug  
          events (ADEs)) are among the most common medical errors, harming  
          at least 1.5 million people every year.  While researchers state  
          that there is insufficient data to accurately determine the cost  
          of medication errors, conservative estimates suggest that the  
          cost of treating drug-related injuries occurring in hospitals  
          alone amount to $3.5 billion a year.  Medication errors occur  
          much more frequently than preventable ADEs, perhaps on the order  
          of 100 times more often.  Medication errors also occur in  
          physicians' offices, pharmacies, and home care.  Unfortunately,  
          there are very little data describing the extent of the problem  
          outside of hospitals.  

          MedWatch is a voluntary reporting system established for health  
          professionals and consumers to report serious ADEs, product  
          problems, or medication errors they suspect are associated with  
          the drugs or medical devices they prescribe, dispense, or use.   
          MedWatch followed another federal Food and Drug Agency (FDA)  
          voluntary-reporting program started in 1961.  MedWatch reporting  
          can be done online, by phone, or by submitting a form via mail  
          or fax.  

          The FDA also has a mandatory ADE reporting process for drug  
          manufacturers who are required to report to the FDA any  
          suspected ADE reports within 15 days of receipt.  In addition,  
          user facilities such as hospitals and nursing homes are legally  
          required to report suspected medical device-related deaths or  
          injuries to both FDA and the manufacturer.

           Previous legislation  .  SB 1339 (Figueroa), Chapter 677, Statutes  
          of 2000, requires pharmacies to establish quality assurance  
          programs to reduce medication errors and requires the Board to  
          adopt a regulation specifying the requirements.

          SB 380 (Alquist), of 2005 required health care providers to  
          report suspicious serious ADEs to the FDA.  This bill was held  








                                                                  AB 1916
                                                                  Page  3

          on the Assembly Floor.  

           REGISTERED SUPPORT / OPPOSITION  :   

           Support 
           
          None on file.

           Opposition 
           
          California Retailers Association
          California Society of Health-System Pharmacists
          National Association of Chain Drug Stores
           
          Analysis Prepared by  :    Sarah Weaver / B.,P. & C.P. / (916)  
          319-3301